Prelude Therapeutics Incorporated (PRLD)
NASDAQ·Healthcare·Biotechnology
$3.52
-2.22%
Mkt Cap $196.21M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$7.00
Range $3.00 – $10.00
Implied Upside
+98.9%
Consensus $7.00 vs current $3.52
NASDAQ·Healthcare·Biotechnology
$3.52
-2.22%
Mkt Cap $196.21M
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$7.00
Range $3.00 – $10.00
+98.9%
Consensus $7.00 vs current $3.52